These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 306461)

  • 21. [Pharmacokinetic and clinical research on a new antibiotic combination (amoxicillin and flucloxacillin in equivalent-weight dose)].
    Di Nola F; Soranzo ML; Bosio G; Sachelariu N; Mastroviti S
    Minerva Med; 1977 Mar; 68(14):917-28. PubMed ID: 321992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of lysozyme-sensitive mutants of Staphylococcus aureus.
    Inoue M; Okubo T; Oshima H; Saito T; Kato M; Mitsuhashi S
    J Bacteriol; 1980 Dec; 144(3):1186-9. PubMed ID: 7440506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experience in use of amoxicillin for treatment of acute cystitis (author's transl)].
    Unno R; Yamamoto Y
    Jpn J Antibiot; 1976 Jan; 29(1):11-6. PubMed ID: 772243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enzymatic lysis of staphylococci in relation to their species and strain properties].
    Babenko IuS; Ghilomedova LE; Kukushkina NV
    Antibiot Khimioter; 1990 Mar; 35(3):20-2. PubMed ID: 2360850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bactericidal activity of amoxicillin and cefaclor in an "in vitro" kinetic model (author's transl)].
    Pothier P; Kazmierczak A; Siebor E; Gaillard MC; Pechinot A
    Ann Microbiol (Paris); 1981; 132(3):293-306. PubMed ID: 7027869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Choice of amoxycilin dosage in impaired renal function (author's transl)].
    Dzúriková V; Simkovicová M; Fedelesová V; Dzúrik R
    Bratisl Lek Listy; 1978 Apr; 69(4):468-73. PubMed ID: 638809
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of a lysoenzyme preparation from Streptomyces recifensis subsp. lyticus 2435 for isolating DNA from staphylococcal cells].
    Babenko IuS; Oriabinskaia LB
    Antibiot Khimioter; 1990 Mar; 35(3):17-20. PubMed ID: 2113799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative characteristics of lysozymes of different origin].
    Podboronov VM
    Antibiot Khimioter; 1990 Aug; 35(8):22-5. PubMed ID: 2264747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibacterial activity of a lysozyme-like enzyme from staphylococci].
    Afanas'eva TI; Leonenko VA; Kravchenko NA; Cherkasova IA; Safonova TB
    Antibiotiki; 1975 Oct; 20(10):907-11. PubMed ID: 813563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on plasmid DNA of Streptococcus mutans (author's transl)].
    Katayama A; Ishikawa E; Arai T
    Josai Shika Daigaku Kiyo; 1978; 7(1):39-47. PubMed ID: 292480
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacokinetic analyses of the absorption of ampicillin and amoxicillin into the blood and experimentally infected skin after simultaneous administration of an antibiotic with bromelain and lysozyme].
    Komiya M
    Nichidai Koko Kagaku; 1986 Sep; 12(3):246-60. PubMed ID: 3467190
    [No Abstract]   [Full Text] [Related]  

  • 32. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin].
    Acar N; Diri MC; Türkyilmaz FR
    Mikrobiyol Bul; 1987 Oct; 21(4):284-8. PubMed ID: 3332705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibacterial and pharmacokinetic actions of amoxicillin].
    Duval J; Soussy CJ
    Nouv Presse Med; 1975 Oct; 4(34):2433-6. PubMed ID: 812057
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of typhoid and paratyphoid fever with amoxicillin (author's transl)].
    Frick P; Zunino E; Riofrio P; Salcedo M
    Rev Med Chil; 1975 Sep; 103(9):613-4. PubMed ID: 813288
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus.
    Bera A; Biswas R; Herbert S; Kulauzovic E; Weidenmaier C; Peschel A; Götz F
    J Bacteriol; 2007 Jan; 189(1):280-3. PubMed ID: 17085565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriolytic enzyme produced by Acanthamoeba castellanii.
    Drozański W
    Acta Microbiol Pol A; 1969; 1(3):155-68. PubMed ID: 5369723
    [No Abstract]   [Full Text] [Related]  

  • 37. A kinetic study of the bacteriolytic and bactericidal action of human serum.
    Glynn AA; Milne CM
    Immunology; 1967 Jun; 12(6):639-53. PubMed ID: 5338688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of nalidixic acid on the conversion of Staphylococcus aureus cells to L-forms in a liquid medium with 6-aminopenicillanic acid and lysozyme.
    Yabu K
    Microbiol Immunol; 1986; 30(8):811-8. PubMed ID: 3023798
    [No Abstract]   [Full Text] [Related]  

  • 39. Antimicrobial resistance of Staphylococcus aureus and oral streptococci strains from high-risk endocarditis patients.
    Groppo FC; Castro FM; Pacheco AB; Motta RH; Filho TR; Ramacciato JC; Florio FM; Meechan JG
    Gen Dent; 2005; 53(6):410-3. PubMed ID: 16366048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteriolytic activity of lysozyme in the nasal mucosa.
    Tachibana M; Morioka H; Machino M; Mizukoshi O
    Auris Nasus Larynx; 1986; 13(2):97-9. PubMed ID: 3813985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.